Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

26

Revenue 2017

Victoza

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Victoza was produced by Novo Nordisk.

Novo's world-leading insulin plant to get even bigger

Novo's world-leading insulin plant to get even bigger insulin degludec) and Victoza (liraglutide).

Ypsomed’s touch screen insulin pump for Novo Nordisk approved by EMA

Ypsomed’s touch screen insulin pump for Novo Nordisk approved by EMA It's GLP-1 agonist Victoza (liraglutide) brought in sales of $2bn in 2014 alone, and is predicted for further growth after trial results published earlier this month showed positive cardiovascular

Victoza cuts cardiovascular risk in landmark study

Victoza cuts cardiovascular risk in landmark study Novo Nordisk’s diabetes therapy outcomes ‘beyond expectations’. Novo Nordisk's GLP-1 agonist Victoza has become the second drug to show a positive benefit in a large-scale cardiovascular outcomes ... Victoza has been approved for the treatment of

FDA advisors back Novo Nordisk's IDeglira combination

FDA advisors back Novo Nordisk's IDeglira combination Unanimous vote is a step forward for the Tesiba-Victoza injection. Novo Nordisk has won unanimous backing from FDA advisors for the approval of IDeglira, its once-daily, fixed-dose combination ... Tresiba (insulin degludec) and Victoza (liraglutide).

Harnessing commercial innovation

Harnessing commercial innovation He highlights the global roll-out of its blockbuster diabetes drug Victoza - currently one of the 50 best-selling medicines in the world - as a prime example of how these functions

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Apex.co.uk Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...

Latest intelligence

Multichannel engagement and the need for greater understanding of European markets
By Laurence Olding and Georgina James...
A snapshot of… Exscientia
...
Patients are ready for virtual clinical trials, are you?
Traditional clinical trial designs simply can’t withstand the impact of COVID-19. While before the pandemic, some in clinical research were beginning to adopt virtual components, the move towards designing hybrid...

Infographics